Sandhya Girish

Company: Gilead Sciences

Job title: Vice President Clinical Pharmacology

Seminars:

Discussing Dosing Considerations in the Development of CPIs: PD1/L1 & TIGIT Therapies 12:00 pm

• Clinical pharmacology of checkpoint inhibitors is well understood given the wealth of data • Outlining quantitative approaches that can help with optimizing dose for monotherapy and combination treatments • Addressing the confounding factors at play in assessing the impact of therapies on outcomesRead more

day: Day Two